RecruitingNCT03400371
Biology of Juvenile Myoclonic Epilepsy
Studying Juvenile myoclonic epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- King's College London
- Principal Investigator
- K Pal, MD PhDKing's College London
- Intervention
- Blood draw(other)
- Enrollment
- 1000 enrolled
- Eligibility
- 10-40 years · All sexes
- Timeline
- 2017 – 2026
Study locations (15)
- Mount Sinai-Beth Israel Medical Center, New York, New York, United States
- St Luke's Roosevelt Hospital, New York, New York, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Hospital for Sick Kids, Toronto, Ontario, Canada
- Charles University, Prague, Czechia
- Danish National Epilepsy Centre, Dianalund, Denmark
- Tallinn Children's Hospital, Tallinn, Estonia
- University Robert Debré, Paris, France
- Commissione Genetica Lega Italiana contro l'Epilepssia, Roma, Italy
- Vestre Viken Health Trust, Oslo, Drammen, Norway
- Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom
- Royal London Hospital, London, United Kingdom
- St Thomas' Hospital, London, United Kingdom
- King's College Hospital NHS Trust, London, United Kingdom
- Swansea University, Swansea, United Kingdom
Collaborators
King's College Hospital NHS Trust · Charles University, Czech Republic · Hopital Universitaire Robert-Debre · Vestre Viken Hospital Trust · The Hospital for Sick Children · Cardiff University · Odense University Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03400371 on ClinicalTrials.gov